GB0412526D0 - Type 2 diabetes - Google Patents

Type 2 diabetes

Info

Publication number
GB0412526D0
GB0412526D0 GB0412526A GB0412526A GB0412526D0 GB 0412526 D0 GB0412526 D0 GB 0412526D0 GB 0412526 A GB0412526 A GB 0412526A GB 0412526 A GB0412526 A GB 0412526A GB 0412526 D0 GB0412526 D0 GB 0412526D0
Authority
GB
United Kingdom
Prior art keywords
diabetes
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0412526A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GB0412526A priority Critical patent/GB0412526D0/en
Publication of GB0412526D0 publication Critical patent/GB0412526D0/en
Priority to PCT/BE2005/000091 priority patent/WO2005120474A2/fr
Ceased legal-status Critical Current

Links

GB0412526A 2004-06-05 2004-06-05 Type 2 diabetes Ceased GB0412526D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0412526A GB0412526D0 (en) 2004-06-05 2004-06-05 Type 2 diabetes
PCT/BE2005/000091 WO2005120474A2 (fr) 2004-06-05 2005-06-06 Inhibiteurs de la phosphodiesterase 10a pour amplifier l'action de mimetiques glp1 ou d'inhibiteurs dpp-iv dans des diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0412526A GB0412526D0 (en) 2004-06-05 2004-06-05 Type 2 diabetes

Publications (1)

Publication Number Publication Date
GB0412526D0 true GB0412526D0 (en) 2004-07-14

Family

ID=32732119

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0412526A Ceased GB0412526D0 (en) 2004-06-05 2004-06-05 Type 2 diabetes

Country Status (2)

Country Link
GB (1) GB0412526D0 (fr)
WO (1) WO2005120474A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009530231A (ja) * 2006-01-20 2009-08-27 スミスクライン ビーチャム コーポレーション 代謝及び神経系の疾患の治療におけるスルホンアミド誘導体の使用
CN102985557B (zh) 2009-03-13 2018-06-15 安吉奥斯医药品有限公司 用于细胞增殖相关病症的方法和组合物
JP5756457B2 (ja) 2009-04-06 2015-07-29 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼｍ２調節剤、治療組成物および関連する使用方法
SG10201403696UA (en) 2009-06-29 2014-10-30 Agios Pharmaceuticals Inc Therapeutic compounds and compositions
CA2793835C (fr) 2009-10-21 2021-07-20 Agios Pharmaceuticals, Inc. Procedes et compositions pour des troubles relatifs
WO2011088524A1 (fr) * 2010-01-25 2011-07-28 Monash University Procédés pour réguler la glycémie
ES2564952T3 (es) 2010-12-17 2016-03-30 Agios Pharmaceuticals, Inc. Nuevos derivados de N-(4-(azetidina-1-carbonil)fenil)-(hetero-)arilsulfonamida como moduladores de piruvato quinasa M2 (PKM2)
MX336022B (es) 2010-12-21 2016-01-06 Agios Pharmaceuticals Inc Activadores de pkm2 bicíclicos.
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
SI2704721T1 (en) 2011-05-03 2018-08-31 Agios Pharmaceuticals, Inc. ACTIVATORS PIANO KINASE FOR USE IN THERAPY
JP6267112B2 (ja) 2011-05-03 2018-01-24 アジオス ファーマシューティカルズ， インコーポレイテッド ピルビン酸キナーゼアクチベーターの使用方法
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
US20150119399A1 (en) * 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
EP3019480B1 (fr) 2013-07-11 2020-05-06 Agios Pharmaceuticals, Inc. Composés 2,4- ou 4,6-diaminopyrimidine comme inhibiteurs d'idh2 mutantes pour le traitement du cancer
WO2015003355A2 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs et leurs méthodes d'utilisation
WO2015003360A2 (fr) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Composés thérapeutiquement actifs et leurs méthodes d'utilisation
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
KR20220070066A (ko) 2014-03-14 2022-05-27 아지오스 파마슈티컬스 아이엔씨. 치료적으로 활성인 화합물의 약제학적 조성물
AU2016276951B2 (en) 2015-06-11 2020-10-08 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
SG10202111439SA (en) 2015-10-15 2021-11-29 Les Laboratoires Servier Sas Combination therapy for treating malignancies
PL3362066T3 (pl) 2015-10-15 2022-05-02 Les Laboratoires Servier Terapia skojarzona do leczenia nowotworów złośliwych
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020037829A1 (en) * 2000-08-23 2002-03-28 Aronson Peter S. Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
US20030060494A1 (en) * 2001-05-18 2003-03-27 Nobuyuki Yasuda Pharmaceutical use of N-carbamoylazole derivatives
JP4187462B2 (ja) * 2001-05-18 2008-11-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｎ−カルバモイルアゾール誘導体の医薬用途
JP4329381B2 (ja) * 2002-04-04 2009-09-09 田辺三菱製薬株式会社 医薬組成物
JP2004026820A (ja) * 2002-05-09 2004-01-29 Taisho Pharmaceut Co Ltd ジペプチジルペプチダーゼｉｖ阻害剤
US20070105840A1 (en) * 2003-06-30 2007-05-10 Altana Pharma Ag Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
WO2005012485A2 (fr) * 2003-07-31 2005-02-10 Bayer Pharmaceuticals Corporation Procedes pour traiter le diabete, et les troubles associes, au moyen d'inhibiteurs des pde10a

Also Published As

Publication number Publication date
WO2005120474A2 (fr) 2005-12-22
WO2005120474A3 (fr) 2006-03-23

Similar Documents

Publication Publication Date Title
GB0412526D0 (en) Type 2 diabetes
AP2832A (en) Pesticidal composition
EP1830858A4 (fr) 3,6-bicyclolides
GB0425572D0 (en) 1,7-Naphthyridines
GB0403059D0 (en) Xigence version 1.0
GB2409587B (en) 'Kwicap'
GB0417150D0 (en) Hydrodyne 2
PL114818U1 (en) V .03
GB2423638B (en) Time-light 2000
GB0411613D0 (en) Webhead 1
GB0412160D0 (en) Facescan 1
GB0414490D0 (en) Isobutt types 1/2
GB0423482D0 (en) 3 way extend-a-boom
GB0404377D0 (en) Design 5
GB0404376D0 (en) Design 4
GB0407065D0 (en) Concept 16
GB0426768D0 (en) Concept 16 b
GB0403746D0 (en) 2031 Oxidoreductase
GB0424080D0 (en) 2031 Oxidoreductase
GB0414385D0 (en) Innovation 2
GB0414395D0 (en) Innovation 6
GB0414398D0 (en) Innovation 9
GB0414397D0 (en) Innovation 8
GB0414396D0 (en) Innovation 6
GB0414450D0 (en) Innovation 1

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)